There are many ways to estimate the value of a company. One ratio that is popular with value investors, in particular, is the price/book ratio, which compares a company’s share price with its book value.
So what is book value? Quite simply, it’s the total value of a company’s assets after subtracting all of its liabilities. You can find it in the balance sheet section of a company’s annual report. It’s also known as shareholders’ equity or net asset value.
Assets come in two main types. Tangible assets include land, machinery, cash - anything you can “touch” (including cash in the bank, and other financial assets such as shares). Intangible assets include the value of a brand, or intellectual property rights – assets that you can’t touch, but which definitely have a value.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Intangible assets are harder to put a specific value on than tangible assets. It’s a lot easier to know what a fleet of vehicles is worth today than it is to put a precise value on a brand at any given point in time. Moreover, many of the costs that create intangible value (such as spending on research and development) never end up being recorded on the balance sheet as a result of accounting conventions.
Yet for many companies – tech stocks are an obvious example, but consumer goods companies are another – the value of the intangible assets may well be far greater than any physical assets they own. As a result, book value is arguably more useful for valuing companies with lots of tangible assets, such as housebuilders or banks.
If you divide the share price by the book value per share, this can give you an idea of whether the company is cheap or expensive. A price/book value of less than one means that, in theory, you can buy the company for less than its assets are worth.
In other words, if you had the means to buy the whole company, you could buy it, then sell off all of its assets immediately, and still make a profit. Of course, it may also imply that investors are sceptical as to the real value of the company’s assets.
-
HMRC confirms crypto ETN ISA rulesWith crypto ETNs now technically available for UK retail investors, HMRC has confirmed they can be held in an ISA – but there’s a complication
-
Pensioners targeted in fine wine scams – the tactics to watch forWine has emerged as the latest lure in investment fraud, with pensioners being specifically targeted by scammers
-
Pierre-Édouard Stérin wants to make France great againConservative billionaire Pierre-Édouard Stérin is seeking to lead a political and spiritual renaissance across the Channel. The planning looks meticulous
-
Global investors have overlooked the top innovators in emerging marketsOpinion Carlos Hardenberg, portfolio manager, Mobius Investment Trust, highlights three emerging market stocks where he’d put his money
-
Pinewood Technologies: a drive for growthPinewood Technologies’ platform is one of the best in the business. Investors should buy in
-
'EV maker Faraday Future will crash'Faraday Future Intelligent Electric is failing dismally to live up to its name, says Matthew Partridge
-
Investors should cheer the coming nuclear summerThe US and UK have agreed a groundbreaking deal on nuclear power, and the sector is seeing a surge in interest from around the world. Here's how you can profit
-
8 of the best houses for sale with folliesThe best houses for sale with follies in the grounds – from a five-storey Victorian Gothic tower in Tonbridge, Kent, to a former mill in Oxfordshire with gardens that include a folly on an island in a lake
-
A tale of two Reits – why performance matters for valuationAEW UK and Regional are two Reits that are valued very differently, despite a shared focus on properties outside London
-
Healthcare stocks look cheap, but tread carefullyShares in healthcare companies could get a shot in the arm if uncertainty over policy in the US wanes, but are they worth the risk?
